What's Happening?
10x Genomics has acquired Proteintech Genomics to enhance its proteomics capabilities, aiming to integrate single-cell and spatial biology platforms with advanced protein detection technologies. This acquisition is part of 10x Genomics' strategy to expand
its multiomics presence, combining RNA and protein analysis to provide comprehensive insights into cellular functions. Proteintech Genomics, known for its Human Discovery Panel, offers a large antibody-based single-cell protein panel that profiles numerous protein targets alongside transcriptomic measurements. The acquisition is expected to accelerate product development and make high-quality multiomic workflows more accessible to researchers.
Why It's Important?
The acquisition of Proteintech Genomics by 10x Genomics represents a significant step in advancing proteomics, a rapidly evolving area of biology. By integrating protein and RNA analysis, the acquisition enhances the ability to study cellular identity and function, which is crucial for understanding complex biological systems and developing new therapies. This move positions 10x Genomics to lead in the multiomics field, potentially transforming research methodologies and accelerating discoveries in areas such as cancer research and personalized medicine.
